-- Merger to Create a Sustainable Biotechnology Company: Brings Together Significant Product Assets, Unique Discovery Capabilities and Financial Resources - CAMBRIDGE, Mass. & VANCOUVER, British ...
MUNICH & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Brainlab SE (Brainlab), a digital medical technology company automating and optimizing clinical workflows using artificial intelligence and ...
An exclusive out-licensing deal could be worth up to $475 million to Neuromed Pharmaceuticals Ltd., which entered an agreement with Merck & Co. Inc. on N-type calcium channel blockers for pain and ...
Under the terms of the merger agreement, CombinatoRx is expected to issue approximately 36 million new shares of its common stock to Neuromed stockholders with each party owning approximately 50% of ...
-- Merger to Create a Sustainable Biotechnology Company: Brings Together Significant Product Assets, Unique Discovery Capabilities and Financial Resources - CAMBRIDGE, Mass. & VANCOUVER, British ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results